James L. Wade III, MD, FACP, FASCO, discusses the importance of clinical trials in the community.
James L. Wade III, MD, FACP, FASCO, founder of Cancer Care Specialists of Illinois and former President of ACCC, discusses the importance of clinical trials in the community.
Wade says that in the 1980s, researchers believed they only needed the right drug to have a cure for cancer. In the 1990s, the focus was on finding the right dose. Theories like these, bone marrow transplant, and monoclonal antibodies have come and gone, Wade notes.
Nogapendekin Alfa Plus Checkpoint Inhibition Improves Survival in NSCLC
April 25th 2024Following its recent FDA approval in non-muscle-invasive bladder cancer, nogapendekin alfa has also shown overall survival benefits in addition to checkpoint inhibitor therapy in patients with non-small cell lung cancer.
Read More
Management of Immune-Related Toxicities in Melanoma Has Improved Over Time
April 24th 2024During a Case-Based Roundtable® event, Evan J. Lipson, MD, discussed with participants how their experience with immunotherapy toxicities has changed over time in the first article of a 2-part series.
Read More
Emphasizing the Need for NGS in Advanced NSCLC to Determine Treatment
April 23rd 2024During a Case-Based Roundtable® event, Joshua Sabari, MD, led a discussion on the need for next-generation sequencing to determine treatment in patients with EGFR-positive advanced non–small cell lung cancer in the first article of a 2-part series.
Read More